647 related articles for article (PubMed ID: 8143886)
1. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
4. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
Elie R; Rüther E; Farr I; Emilien G; Salinas E
J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
[TBL] [Abstract][Full Text] [Related]
5. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem.
Kryger MH; Steljes D; Pouliot Z; Neufeld H; Odynski T
Sleep; 1991 Oct; 14(5):399-407. PubMed ID: 1759092
[TBL] [Abstract][Full Text] [Related]
6. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
[TBL] [Abstract][Full Text] [Related]
7. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
Krystal AD; Erman M; Zammit GK; Soubrane C; Roth T;
Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
[TBL] [Abstract][Full Text] [Related]
9. Zolpidem, a valuable alternative to benzodiazepine hypnotics for chronic insomnia?
Declerck A; Smits M
J Int Med Res; 1999; 27(6):253-63. PubMed ID: 10726234
[TBL] [Abstract][Full Text] [Related]
10. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
Monti JM; Attali P; Monti D; Zipfel A; de la Giclais B; Morselli PL
Pharmacopsychiatry; 1994 Jul; 27(4):166-75. PubMed ID: 7972349
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
[TBL] [Abstract][Full Text] [Related]
12. Effect of zolpidem on sleep in healthy subjects: a placebo-controlled trial with polysomnographic recordings.
Blois R; Gaillard JM; Attali P; Coquelin JP
Clin Ther; 1993; 15(5):797-809. PubMed ID: 8269446
[TBL] [Abstract][Full Text] [Related]
13. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
Ozone M; Yagi T; Itoh H; Tamura Y; Inoue Y; Uchimura N; Sasaki M; Shimizu T; Terzano MG; Parrino L
Pharmacopsychiatry; 2008 May; 41(3):106-14. PubMed ID: 18484552
[TBL] [Abstract][Full Text] [Related]
14. Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder.
Saletu-Zyhlarz G; Anderer P; Brandstätter N; Dantendorfer K; Gruber G; Mandl M; Ritter K; Zoghlami A; Saletu B
Neuropsychobiology; 2000; 41(3):139-48. PubMed ID: 10754428
[TBL] [Abstract][Full Text] [Related]
15. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.
Voderholzer U; Riemann D; Hornyak M; Backhaus J; Feige B; Berger M; Hohagen F
Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):117-23. PubMed ID: 11697572
[TBL] [Abstract][Full Text] [Related]
17. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study.
Roehrs TA; Randall S; Harris E; Maan R; Roth T
J Psychopharmacol; 2012 Aug; 26(8):1088-95. PubMed ID: 22004689
[TBL] [Abstract][Full Text] [Related]
18. The dose effects of zolpidem on the sleep of healthy normals.
Merlotti L; Roehrs T; Koshorek G; Zorick F; Lamphere J; Roth T
J Clin Psychopharmacol; 1989 Feb; 9(1):9-14. PubMed ID: 2651493
[TBL] [Abstract][Full Text] [Related]
19. Dose response effects of zolpidem in normal geriatric subjects.
Scharf MB; Mayleben DW; Kaffeman M; Krall R; Ochs R
J Clin Psychiatry; 1991 Feb; 52(2):77-83. PubMed ID: 1993640
[TBL] [Abstract][Full Text] [Related]
20. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
Dorsey CM; Lee KA; Scharf MB
Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
